Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Metlife (MET-PA) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Metlife (MET-PA) over the last 17 years, with Q3 2025 value amounting to 18.41%.

  • Metlife's EBITDA Margin fell 78200.0% to 18.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.64%, marking a year-over-year increase of 28800.0%. This contributed to the annual value of 29.97% for FY2024, which is 2100.0% up from last year.
  • According to the latest figures from Q3 2025, Metlife's EBITDA Margin is 18.41%, which was down 78200.0% from 6.49% recorded in Q2 2025.
  • Metlife's 5-year EBITDA Margin high stood at 29.56% for Q4 2021, and its period low was 47.02% during Q1 2021.
  • Over the past 5 years, Metlife's median EBITDA Margin value was 8.23% (recorded in 2021), while the average stood at 3.77%.
  • Per our database at Business Quant, Metlife's EBITDA Margin tumbled by -749700bps in 2022 and then surged by 617800bps in 2023.
  • Quarter analysis of 5 years shows Metlife's EBITDA Margin stood at 29.56% in 2021, then dropped by -3bps to 28.6% in 2022, then fell by -1bps to 28.2% in 2023, then grew by 3bps to 28.96% in 2024, then crashed by -36bps to 18.41% in 2025.
  • Its last three reported values are 18.41% in Q3 2025, 6.49% for Q2 2025, and 15.94% during Q1 2025.